This guidance document provides practical indications for the initiation and rapid titration of guideline-directed medical therapy in heart failure to address suboptimal implementation and under-dosing.
Provides practical guidance for cardiologists, general practitioners, and internal medicine doctors to improve the implementation and rapid titration of guideline-directed medical therapy in heart failure.
Physicians' adherence to guideline-recommended heart failure (HF) treatment remains suboptimal, especially regarding the target doses. In particular, there is evidence that non-cardiologists are less compliant with HF guideline recommendations. This is likely to have a detrimental impact on patients' survival, readmissions and quality of life. Thus, the present document aims to address the reasons underlying low implementation and under-dosing of guideline-directed medical therapy in HF and to update a guidance for the initiation and rapid titration of HF drugs. In particular, aim of this document is to provide practical indications for drug implementation, to be applied not only by cardiologists but also by GPs and internal medicine doctors.
Volterrani et al. (Wed,) conducted a review in Heart Failure. Guideline-directed medical therapy was evaluated. This guidance document provides practical indications for the initiation and rapid titration of guideline-directed medical therapy in heart failure to address suboptimal implementation and under-dosing.